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Summary.-Diethylnitrosamine (DENA) at 10 mg/kg/day was fed to adult rats either
continuously or for periods ranging from 1 to 10 weeks. Survival correlated inversely
with the duration of carcinogen feeding. Less than 4 weeks of DENA feeding produced
only preneoplastic foci that persisted indefinitely; 4 weeks were found to be necessary
for the transformation of preneoplastic lesions into liver cancers; after 6 weeks, the
incidence of hepatomas was 100%. The process of liver cancerization appeared to be
identical whether DENA was fed for 8 weeks or continuously up to the time of death.
These results are discussed in the light ofthe evolution ofthe homoeostatic control of
liver-cell division during DENA feeding, in order to distinguish the different
successive roles played by the carcinogen.
WE HAVE PREVIOUSLY shown that when
liver tumours are induced in rats by
chronic administration of diethylnitros-
amine (DENA) at a daily dose of 10
mg/kg, the carcinogenesis can be divided
into 3 different steps.
The difference of behaviour during
these 3 steps was based on proliferative
and functional criteria as well as on the
evolution of PAS+ foci and areas (Van
Cantfort & Barbason, 1975; Barbason et
al., 1976, 1977). These PAS+ foci show no
glycogen depletion in hepatocytes after
18-h fasting, appear to be clonal in origin
and give rise to nodular formation.
According to different authors, they
actually represent preneoplastic lesions
(Bannasch, 1968; Friedrich-Freska et al.,
1969; Scherer & Hoffmann, 1971; Scherer
et al., 1972; Daoust & Calamai, 1-971;
Farber, 1973).
During the first step, corresponding to
the first month of treatment, the drug-
induced necroses give rise to cell prolifera-
tion, reaching a maximum after 2 weeks.
The preneoplastic foci are induced during
this first step, but the homoeostatic control
of cell proliferation and functions remains
normal.
During the second step, corresponding
to the second month of treatment, the
activity of cell division and function is
low, the foci and areas increase in size but
their number remains unchanged. At this
stage, the homoeostatic control is pro-
gressively lost.
The third step corresponds to the third
month when neoplastic growth istriggered.
It thus seems that the action of the
carcinogen is due to different successive
mechanisms corresponding to the three
steps we have observed.
On the other hand, it has been shown
that the effect of continuous administra-
tion of carcinogen is independent of the
size of the individual dose, but is essenti-
ally a function ofthe total dose, suggesting
an "irreversible summation" during the
time of administration (Druckrey et al.,
1962). Moreover, even at very low daily
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doses of 0 3 mg/kg DENA almost 100% of
the animals were harbouring cancer at the
time ofdeath.
However, such a continuous administra-
tion of a carcinogen obviously shows only
the end point ofseveral possible successive
mechanisms.
To demonstrate any intermediate step
in the action of the carcinogen, experi-
ments were therefore performed in which
DENA feeding was discontinued after
various intervals. In the different experi-
mental modalities, the survival curves and
the evaluation of the liver lesions (pre-
neoplastic foci, neoplastic nodules and
hepatomas) were studied.
MATERIALS AND METHODS
Male Wistar rats, weighing 180 g, wAere
submitted to chronic administration of
DENA. The carcinogen Awas given in drinking
water at a concentration of 80 mg/I. wOhich
represents an ingested dose of 10 mg/kg/
day.
Experiments were divided into two parts.
In the first, the animals were divided into 7
groups of 15-20 each. In the first group, the
treatment continued throughout the experi-
ment. In the other groups, the treatment wN-as
stopped after 1, 2, 4, 6, 8 and 10 weeks
respectively. The animals wNere observed daily
during the whole experiment, i.e. 2 years. Ani
autopsy was performed either after spon-
taneous death or after killing moribund
animals. Histological slides wAere prepared
from all livers and from other organs with
gross lesions. Survival curves were estab-
lished in a probit-log grid by plotting the
surviving fraction after the death of each
animal. The regression line was calculated for
the straight portion of the curve. The median
time until death (T) and the corresponding
total ingested dose (D) were calculated. In
each experimental group there were at least
15 animals whose time of death wa-s accur-
ately known and which wAere suitable for
pathological examination. In the second part
of the experiment groups of animals were
killed at different times from the beginning of
the DENA feeding.
The animals were fasted for 18 h before
death. At autopsy, specimens of gross lesions
and of macroscopically normal liver were
fixed in Bouin's fluid for the diagnosis of
neoplastic nodules and cancers. Ten pieces of
liver tissue wNere taken at random, fixed in
Gendre's fluid by the method previously
described (Barbason et al., 1977) and PAS
stained for the demonstration of preneo-
plastic foci in animals -without neoplastic
nodules or cancer.
The foci, neoplastic nodules and hepato-
carcinomas were defined according to Squire
& Levitt (1975). The difference bet-ween the
foci and neoplastic nodules is based princi-
pally on the size of the lesions, the liver
architecture and the staining properties. The
terms foci or "areas" are restricted to small
lesions, usually less than a liver lobule in size,
without disruption of the liver architecture
and presenting homogeneous and -well-
delimited PAS+ areas of hepatocytes. The
term neoplastic nodules is used for lesions
usually occupying an area larger than a liver
lobule and presenting distortion of liver
architecture. They often show a mixture of
staining properties. Moreover, at least part of
the nodule presents a sharp demarcation by
the compression ofthe surrounding liver cells.
Most of these nodules are macroscopically
visible.
Wte want to point out that, in our con-
ditions. the appearance of neoplastic nodules
and hepatomas does not exclude the presence
of foci, whilst the report of foci persistence
implies that other lesions have not yet
developed.
RESULTS
(1) Survival curves and pathological diag-
nosis at autopsy
All treated animals died before the
controls. In our strain of rats, the mort-
ality is negligible between the 2nd and the
25th months of life, whilst in all experi-
mental groups no animal survived longer
than 25 months.
In all experimental groups (Fig. 1)
20% of the animals died between the
first half of the 2nd and the end of the 3rd
mointh after the beginning of DENA
feeding. In none ofthese animals was liver
tumour found at autopsy. Afterwards, the
survival curves are clearly distinct, with
steeper slopes and shorter median survival
times (T) with increasing duration of
DENA treatment (Table I).
When the treatment was either con-
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FIG. 1. Survival cturves plotte(d against time in a probit/log gri(d (each point correspon(ds to the
(leath of one animal). Zero on the abscissa corresponds to the beginning of DENA feeding. The
arrows in(licate the interval at which frank hepatomas first appear.
Experimental groups: Administration of DENA discontinued after (O) 1 week; (e) 2 weeks;
(3) 4 weeks; (A) 6 weeks: (it) 8 weeks; ( x ) 10 weeks. (0) Contintuous a(dministration of DENA.
TABLE I. Slopes of the survival curve
(calculated by the method of regression),
median survival time (T) and mean total
dose (D) as a function of the duration of
DENA feeding
No.
animals
20
20
25
25
15
15
15
D)urationl
(in days) of
DENA
feedling
(I 0 mg/kg)
7
15
28
42
56
70
contilluouls
Slope of
CUI'\-e
moith)
5-1
5*1
8-1
9-6
42-3
76 8
84-9
T
(days)
436
423
32:3
267
124
109
100
I)
(mg/kg)
70
15(
280
420
560
700
1000
tinuous or stopped after 10 or 8 weeks, the
survival curves dropped sharply from the
90th, 97th and 103rd day respectively (see
corresponding arrows, Fig. l). In all these
animals, autopsy disclosed hepatomas,
mainly of the hepatocellular type. Some-
times the tumours developed in cirrhotic
livers; luna metastases were occasionally
found.
When the treatment was stopped earlier,
i.e. after 1, 2, 4 or 6 weeks, a few animals
died around the 4th month without
tumour.
When the carcinogen feeding was
stopped after I or 2 weeks, the survival
was the longest and no tumour was found
at autopsy, but lung infections were
frequent.
In the group where DENA administra-
tion was discontinued after 4 weeks, there
were no tumours in the animals whose
death is plotted on the upper part of the
survival curve; the animals dying later
on, i.e. from the 12th month (see corres-
ponding arrow, Fig. 1) displayed either
frank liver cancers or macroscopically
visible liver nodules ranging in diameter
from 2 mm to several cm. These lesions
consisted of a disorganized proliferation of
both hepatocytes and bile ducts growing
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in a haphazard way, but with few cell
monstrosities and little evidence of in-
vasion of adjacent parenchyma. They
were diagnosed either as atypical re-
generative nodules or genuine malignant
tumours.
When the carcinogen feeding lasted 6
weeks, all animals died with malignant
tumours of either hepatocellular or mixed
type from the 7th month (see correspond-
ing arrow, Fig. 1).
(2) Evolution of "preneopla8tic" foci, neo-
plastic nodules andhepatoma8 (TableII)
In the group of animals where DENA
feeding was discontinued after 2 weeks,
the foci persisted for at least 14 months,
without any other gross or microscopical
neoplastic lesion.
In animals fed for 4 weeks, the foci were
found without any other lesion for 6
months. At the 9th month, 12/20 animals
showed neoplastic nodules, often asso-
ciated with hepatocareinomas. The other
animals showed only preneoplastic foci.
When DENA feeding was stopped after
6 weeks, the foci persisted in all the
animals killed at 21 months; all the
animals examined at 3 months showed
neoplastic nodules, often associated with
carcinomas, and 100% cancerization was
found after the 4th month.
In animals fed either for I0 weeks or
continuously up to the time of death, the
neoplastic nodules appeared around the
75thday after thebeginning ofthe DENA
feeding and 100% ofthe animals had liver
cancer at the end of the 3rd month.
DISCUSSION
Our present results show that a daily
ingested dose (10 mg/kg) of DENA has
different effects, depending on the dura-
tion ofDENAfeeding.
Animals fed for less than 4 weeks have
a shorter life span than the controls; the
PAS+ foci persist during the whole experi-
ment, but neoplastic nodules and liver
cancers are never found.
After 4 weeks ofDENAtreatment, 50%
of the animals develop neoplastic nodules
and hepatomas from the 9th experimental
month and the same fraction of animals
die either with malignant hepatomas or
with tumours ofquestionable malignancy.
If the DENA is administered for more
than 4 weeks, the lonoer the treatment,
the earlier the animals die with liver
cancer; after 6-week DENA feeding, all
TABLEII.-Liverpathology atdifferentinterval8after the beginningofDEAAfeeding as a
function of the duration of treatment; presence ofpreneoplasticfoci without any other
lesions (F); appearance ofneoplastic nodules (INI) andhepatomas(H).Thefigure8between
brackets indicate theproportion of animals withP08itive,findings
Duration (in
weeks)of Intei
DENA feeding
(IOmg/kg/(Iay) I
4)
4
6
10
20 Contintiolis F 20
Is
,,rval (in months) between the beginning of DENA fee(ling and autopsy
-A.-- -
)I 3 4 6 9 12 14
F 39) F 4
39 4
-N
F 10 F 10) f-o -ro-
10 8 F FO) F(go')
I X+H(
1 2
.o
F 10) 10
F
10
i-o
F 10 N 1-0 H(12) i-o -I9 L-2
H
8
N 10 H 10
(t-o fo-
F 20 1\1 20 H 20
TO 26 26264 H. BARBASON, V. SMOLIAR, A. FRIDMAN-MANDUZIO AND E. H. BETZ
the animals show neoplasti
from the 3rd month and 100O%
are found from the 4th ex
month.
Ifthe treatment is stopped a
weeks, the survival time is
same as when DENA is given
time of death; in these last
neoplastic nodules and cance
synchronously, after about 75 a
respectively.
Thus, by discontinuing the
the persistence of preneoplast
appearance of neoplastic nc
cancers, the mortality and the
at the time of death differ, but
tion of the total dose, and as a
the time when DENA feeding
tinued. Moreover, these diffei
tions also delimit the 3 differe
cancerization which we have
described (see introduction) a
terize the biological events
100 200
ic nodules during the first, second and third months
of cancers oftreatment.
cperimental As to survival (Fig. 2) it is well
known that after continuous administra-
,fter 8 or 10 tion of DENA, ranging from 0 3 to 9-6
almost the mg/kg/day, the relationship between D
up to the (the cumulated daily dose) and T (the
groups, the median time up to death) corresponds to a
ers appear straight line in logarithmic units (Druckrey
Lnd 90days, et al., 1962). If we compare the median
time of death (T) in our experimental
treatment, group receiving continuous DENA feeding
,ic foci, the with a similar experiment by Druckrey
)dules and using an identical accumulated dose, we
- pathology find the same value. However, this is not
t as a func- so when the carcinogen feeding is stopped
function of after various delays. By discontinuing
r is discon- DENA feeding, the relationship between
rent evolu- D and T may be broken down into 3
,nt steps of different components, corresponding to
previously the duration of the 3 steps we have pre-
Lnd charac- viously observed. The same phenomena
occurring may be observed in the evolution of the
lesion. As shown in Fig. 3, the results can
500 T(days) be summarized in the following way:
0
50C
20C
100
E
0
FIG. 2. Cumulative daily (loses (D)) (and the
corresponding months oftreatment) against
the medlian time of death (T) (log girid).
----: Theoretical curve corresponding to
Druckrey's law (slope 1-3).
Our own results: DENA (discontintie(l
after (0) I week; (*) 2 weeks; ( C) 4
weeks; (A) 6 weeks; (A) 8 weeks; (x) 10
weeks. (0) Continuous a(Iministration.
(1) When the treatment is stopped dur-
ing the 3rd month, the persistence of foci,
the appearance of neoplastic nodules and
mortality from cancer follow each other in
the same order as when DENA is given up
to the time ofdeath.
(2) If DENA feeding is discontinued
during the 2nd month, the longer the
treatment the earlier the appearance of
neoplastic nodules, cancers and death
from hepatomas.
(3) At least one month ofDENA feeding
is required to induce liver tumours in our
conditions. Animals fed with DENA for
less than 1 month have a shorter life span
than the controls, but no liver tumour is
found at autopsy. Moreover, the foci re-
main approximately unchanged; they
sometimes increase in size but without any
further transformation into neoplastic
nodules.
This last point seems to be crucial for
the discussion. It may be argued that
animals treated for a short time die too
early to develop their cancer, and that a
I I -1- -r-
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;ic(.. 3.-Durationi of DENA feeding (ordinate in weeks andl months) as a fuinction of the evolution
of the pathological situation (abscissa in months). Zero time represents the beginning of DENA
feeding. F: persistence of PASt foci an(d areas without any other lesion; N: appearance of neo-
plastic no(dtules; H: appearance of hepatomas; T: median time of (leath.
longer life span should be necessary for the
transformation of preneoplastic foci into
malignant tumours. However, it must be
pointed ouit that if we compare our
animals treated for 4 an(I 2 weeks with
those receiving chronically the same
cumulated daily dose (Druckrey et al.,
1 962) (see Fig. 2) the median time ofdeath
is either longer or the same.
However, the tumouir yield also depends
Llpon the experimental design. After 4 and
2 weeks of DENA treatment, respectively,
5000 and 0%0 of cancerization are found,
as compared to nearly 100% in the corres-
pondling animals continuously fed with
1)ENA (Druckrev et al., 1962). This re-
(Iliction in tumour yield when the treat-
ment is discontinued early has already
been observed by Rajewvsky et al. (1966).
Our last results clearly show that while
short, DENA treatment seems to induce
preneoplastic cells and foci, it cannot, by
itself, produce actual liver cancer. Accord-
ing to several authors (Hughes, 1970;
Ogawa et al., 1974; Teebor & Becker, 1971)
utsing other ca.rcinogens, the cessation of a
chronic treatment may be followed by the
regression of preneoplastic lesions and so
prevent the development of cancers. Thus,
to commit irreversibly these foci to
malignancy, the treatment must not be
stopped before a certain threshold, which
corresponds to the 4th week of treatment
in our conditions.
Why must the carcinogen feeding be
protracted up to the 4th week and beyond
to induce and accelerate the malignant
transformation of the foci appearing
during the first month?
It is widely agreed that the carcinogenic
process requires at least 2 steps:
(1) an initial administration which in-
duces mutations fixed by cell divi-
sions (Craddock, 1975);
(2) a subsequent stimulation of growth
of altered foci leading to malignant
hepatocellular carcinoma (Pitot,
1977; Farber et al., 1977).
Some authors have shown that this
second role of the carcinogen could be
played by another carcinogen or even by
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some normally non-carcinogenic sub-
stances (Takayama & Imaizumi, 1969;
Scherer & Emmelot, 1975; Weisburger et
al., 1975; Peraino et al., 1975; Solt &
Farber, 1976; Pitot, 1977; Farber et al.,
1977). It has been recently suggested that
this second role may consist in creating a
"cellular environment" favourable to the
growth of preneoplastic lesions (Farber et
al., 1977).
It has been shown that hepatocytes
from nodular portions of preneoplastic
liver tissue of DENA-fed rats are able to
proliferate in vitro (Rabes et al., 1972). On
the other hand, it has been recently
shown that similar hyperplastic pre-
cancerous liver nodules transplanted into
normal rats appear to revert to a normal
hepatic phenotype (Williams et al., 1977).
Within the limits of our own experi-
mental results, these different successive
steps observed in the genesis ofhepatomas
seem to be related to the irreversible
break-down of the normal homoeostatic
control of liver-cell proliferation and
function (Barbason et al., 1977) as pre-
viously reported by Rabes & Hartenstein
(1970). According to this view, animals
treated for less than one month never
show hepatoinas, perhaps because the
normal homoeostatic regulation of cell
division and function persisting during
this first step prevents the growth of"foci"
andtheirfurthermalignanttransformation.
DENA feeding for more than one month
progressively and irreversibly disturbs this
cell control and could therefore allow the
transformation of foci into neoplastic
nodules. Protracting DENA administra-
tion beyond the 2nd month has no further
effect, perhaps because from this time on
the regulatory mechanism has already
been lost and neoplastic development
becomes autonomous.
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